Stay updated on Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.

Latest updates to the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the ClinicalTrials.gov study page, indicating a minor backend/page metadata update rather than a change to visible content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study footprint expands with two new sites: Vincentius-Diakonissen-Klinken Gag Zentralapotheke in Karlsruhe, Germany and UChicago Medicine at Ingalls in Flossmoor, Illinois, bringing total locations to 175. Yale University in New Haven, CT was removed from the listed sites.SummaryDifference0.2%

- Check27 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4. This reflects a minor metadata/versioning update to the page rather than changes to the study details or content.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision: v3.6.3 replaces the previous Revision: v3.6.2, indicating a minor version update to the page. This change reflects an internal update to the page rather than any modification of study details.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision: v3.6.2 is now displayed, replacing v3.6.0. This indicates a software version update rather than changes to study details.SummaryDifference0.0%

- Check64 days agoChange DetectedThe study page’s navigation labels were standardized (Intervention/Treatment replacing Intervention / Treatment) and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), accompanied by a new revision tag (v3.6.0) while the previous tag (v3.5.5) was removed.SummaryDifference0.2%

Stay in the know with updates to Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.